Exosome-loaded Paclitaxel: Preparation and toxicity evaluation on two glioblastoma cell lines

Authors

  • Abbas Pardakhty Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran | Department of Pharmaceutics, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
  • Hamid Forootanfar Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran | Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
  • Marzie Esmaeeli Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
  • Meysam Ahmadi-Zeidabadi Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
  • Mostafa Pournamdari Department of Medicinal Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
  • Sepehr Afsharipour Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
  • Soodeh Salarpour Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran | Department of Pharmaceutics, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
Abstract:

Objective(s): Exosomes are endogenous nanovesicles act as intercellular communication tools which have been considered to utilize as drug delivery systems. As transporting therapeutic molecules into brain has obstacles, preparing exosomes which have the potential to pass through its barriers is great challenge. Methods: Exosomes isolated from cell culture media of U87 glioblastoma cells were characterized. In the next step, paclitaxel (PTX) was loaded into them to investigate the cytotoxicity of this formulation on two cell line of glioblastoma, U87 and T98G. Pharmaceutical characterizations such as size analysis, PTX encapsulation efficiency and FESEM/TEM imaging of exosomes were also evaluated. Results: CD9 as a biomarker of exosomes was detected in extracted samples to confirm the presence of exosomes.Size analysis and electron microscopy imaging proved nano-range of isolated and drug loaded exosomes. The cytotoxicity of empty exosomes of U87 cells was different on U87 and T98 cells. Exosomes diminished cell viability in U87 cells compared with control group while in T98 cell line they didn’t have any effect on cell viability after 24 or 48 h time intervals. The cytotoxicity of drug loaded exosomes was different at two time intervals where PTX loaded exosomes had no effect or 30 % cell viability decrease on T98 cells after 24 and 48 h, respectively. Conclusions: Increased cytotoxicity of PTX after entrapment into exosomes and BBB transport capability of exosomes promises an appropriate brain drug delivery system for in vivo characterization in GBM animal model.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome.

A sterically stabilized paclitaxel-loaded liposome tailored to target human breast cancer cells was developed, thereby promoting the efficiency of intracellular delivery of paclitaxel through receptor-mediated endocytosis. Results indicated that the targeting moiety (thiolated Herceptin) was successfully coupled to the distal reactive maleimide terminus of the poly (ethylene glycol)-phospholipi...

full text

Cytotoxicity evaluation of Launaea procumbens on two cell lines

Background and objectives: Launaea procumbens is a member of Asteraceae family which can be found in the south part of Iran especially the province of Hormozgan. This plant has got a variety of usage in traditional medicine for curing the skin diseases. In this study, we have investigated the cytotoxic effect of its various extracts at concentrations b...

full text

The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.

BACKGROUND Although paclitaxel is used for hormone-resistant prostate cancer, relapse definitely occurs later. Details of the molecular mechanism responsible for paclitaxel- resistance remain unclear. METHODS We established paclitaxel-resistant cells, DU145-TxR and PC-3-TxR from parent DU145 and PC-3. To characterize these cells, we examined cross-resistance to other anticancer drugs. Express...

full text

Evaluation of miR-34a Effect on CCND1 mRNA Level and Sensitization of Breast Cancer Cell Lines to Paclitaxel

Background: A growing body of literature has revealed the effective role of miR-34a, as a tumor suppressor and regulator of expression of multiple targets in tumorigenesis and cancer progression. This study aimed at evaluating the potential effects of miR-34a alone or in combination with paclitaxel on breast cancer cells. Methods: After miR-34a transduction by lentiviral vectors in two MCF-7 an...

full text

Synergistic Anticancer Effect of Paclitaxel and Noscapine on Human Prostate Cancer Cell Lines

Paclitaxel is the one of the most common chemotherapeutic drugs used for the treatment of prostate cancer. However, its current clinical utility has been limited due to numerous serious side effects and drug resistance. Noscapine is an antitussive opium alkaloid that showed antitumor activity against a variety of cancer while has not exhibited severe side effects. This study investigates the a...

full text

Synergistic Anticancer Effect of Paclitaxel and Noscapine on Human Prostate Cancer Cell Lines

Paclitaxel is the one of the most common chemotherapeutic drugs used for the treatment of prostate cancer. However, its current clinical utility has been limited due to numerous serious side effects and drug resistance. Noscapine is an antitussive opium alkaloid that showed antitumor activity against a variety of cancer while has not exhibited severe side effects. This study investigates the a...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 4  issue 4

pages  239- 246

publication date 2019-12-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023